SGX-listed incorporated company New Silkroutes Group (NSG) has made a joint venture with three parties, including the Singapore subsidiary of China-based Nanshan Group, to develop private equity funds focusing on healthcare and infrastructure in Asia Pacific including Japan and Australia.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
